Claritev (CTEV) Short-Term Debt repayments (2025 - 2026)
Claritev's quarterly Short-Term Debt repayments came in at $40.0 million in Q1 2026, down 20.0% year-on-year from $50.0 million in Q1 2025, and down 27.27% quarter-over-quarter from $55.0 million in Q4 2025.
Claritev has reported Short-Term Debt repayments for 2 years, with the latest figure at $40.0 million in Q1 2026.
- For the quarter ending Q1 2026, Short-Term Debt repayments fell 20.0% year-over-year to $40.0 million; the trailing twelve-month figure through Mar 2026 stood at $200.0 million (up 300.0% YoY), and the FY2025 full-year result was $210.0 million, changed N/A from the prior year.
- Short-Term Debt repayments for Q1 2026 stood at $40.0 million, down from $55.0 million in the prior quarter.
- The five-year high for Short-Term Debt repayments was $105.0 million in Q3 2025, with the low at $40.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Claritev | 456.62 Mn | 428.62 Mn | 175.60 Mn | 40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 Mn |
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 55.00 Mn |
| Dec 31, 2025 | 55.00 Mn |
| Sep 30, 2025 | 105.00 Mn |
| Sep 30, 2025 | 105.00 Mn |
| Mar 31, 2025 | 50.00 Mn |
| Mar 31, 2025 | 50.00 Mn |